Crime & Law · India
US FDA Issues Observations to Indian Pharma Facilities
The U.S. Food and Drug Administration (FDA) has issued observations following inspections of manufacturing facilities belonging to Indian pharmaceutical companies. Dr. Reddy's Laboratories' Hyderabad biologics facility received seven observations, while Aurobindo Pharma's API unit cleared inspection with two observations. These inspections are routine and can impact a facility's compliance status.
How outlets across the spectrum covered it
Left 1 · Centre 1 · Right 1 n = 3
- Left (1): The Hindu
- Centre (1): Business Standard
- Right (1): Republic World